Recombinant Human DEFB129 Protein，His

DEFB129, a member of the defensin family of proteins, is primarily expressed in human tissues, particularly in the male reproductive system. As an antimicrobial peptide, it plays a pivotal role in the innate immune response by exhibiting broad-spectrum activity against various pathogens, including bacteria, viruses, and fungi. Research on DEFB129 has gained traction due to its potential applications in therapeutic development, specifically in enhancing immune responses and serving as a model for designing novel antimicrobial agents. Additionally, investigations into the structural properties of DEFB129 have provided insights into its mechanism of action, revealing that its efficacy stems from its ability to disrupt microbial membranes. Given the rising global concern regarding antibiotic resistance, DEFB129 presents a promising alternative in combating resistant strains. Recent studies have also explored the role of DEFB129 in reproductive health, suggesting that it may be crucial for maintaining the balance of the microflora in the male reproductive tract. Continuous research aims to elucidate the clinical implications of DEFB129, potentially leading to breakthroughs in both infectious disease management and reproductive medicine. Through recombinant protein expression systems, scientists are now able to produce DEFB129 for various experimental applications, facilitating deeper investigations into its biological functions and therapeutic potential.